The Impact of Injectable Opioid Agonist Treatment (iOAT) on Involvement in Criminalized Activities: A Secondary Analysis from a Clinical Trial in Vancouver, BC

Autor: Dobischok S, Guh D, Marchand K, MacDonald S, Lock K, Harrison S, Lajeunesse J, Schechter MT, Oviedo-Joekes E

Publikováno v: Substance Abuse and Rehabilitation, Vol Volume 14, Pp 147-156 (2023)

Sophia Dobischok,1,2 Daphne Guh,2 Kirsten Marchand,2 Scott MacDonald,3 Kurt Lock,2,4 Scott Harrison,3 Julie Lajeunesse,3 Martin T Schechter,2,5 Eugenia Oviedo-Joekes2,5 1Department of Education and Counselling Psychology, McGill University, Montreal,

Externí odkaz: https://doaj.org/article/eb9c6e5ee54c4cc891a23465d2ac4997

Feasibility of Testing Client Preferences for Accessing Injectable Opioid Agonist Treatment (iOAT): A Pilot Study

Autor: Dobischok S, Metcalfe RK, Matzinger EA, Lock K, Harrison S, MacDonald S, Amara S, Schechter MT, Bansback N, Oviedo-Joekes E

Publikováno v: Patient Preference and Adherence, Vol Volume 16, Pp 3405-3413 (2022)

Sophia Dobischok,1 Rebecca K Metcalfe,1 Elizabeth Angela Matzinger,1 Kurt Lock,1,2 Scott Harrison,3 Scott MacDonald,3 Sherif Amara,4 Martin T Schechter,1,5 Nick Bansback,1,5 Eugenia Oviedo-Joekes1,5 1Centre for Health Evaluation & Outcome Sciences, P

Externí odkaz: https://doaj.org/article/38cab7aedfea400389fe43dcf26753d0

'This is PEEP' participatory qualitative study: learning from a provincial consultation and advisory group of people with lived and living experience of substance use in British Columbia, Canada.

Autor: Daowd K; Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada., Lock K; Harm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada., Danaei A; Faculty of Land and Food Systems, The University of British Columbia, Vancouver, British Columbia, Canada., Burmeister C; Harm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada., Choisil P; Harm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada., Haywood E; Harm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada., Henderson I; Harm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada., Lamb J; Harm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada., McDougall J; Harm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada., Sedgemore K; Harm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada., Buxton JA; Harm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada jane.buxton@ubc.ca.; School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada.

Publikováno v: BMJ open [BMJ Open] 2024 Nov 07; Vol. 14 (11), pp. e085183. Date of Electronic Publication: 2024 Nov 07.

Access and barriers to safer supply prescribing during a toxic drug emergency: a mixed methods study of implementation in British Columbia, Canada.

Autor: Urbanoski KA; Canadian Institute for Substance Use Research, University of Victoria, PO Box 1700 STN CSC, Victoria, British Columbia, V8W 2Y2, Canada. urbanosk@uvic.ca.; School of Public Health and Social Policy, University of Victoria, Victoria, BC, V8W 2Y2, Canada. urbanosk@uvic.ca., van Roode T; Canadian Institute for Substance Use Research, University of Victoria, PO Box 1700 STN CSC, Victoria, British Columbia, V8W 2Y2, Canada., Selfridge M; Canadian Institute for Substance Use Research, University of Victoria, PO Box 1700 STN CSC, Victoria, British Columbia, V8W 2Y2, Canada., Hogan KC; Canadian Institute for Substance Use Research, University of Victoria, PO Box 1700 STN CSC, Victoria, British Columbia, V8W 2Y2, Canada., Fraser J; Canadian Institute for Substance Use Research, University of Victoria, PO Box 1700 STN CSC, Victoria, British Columbia, V8W 2Y2, Canada., Lock K; British Columbia Centre for Disease Control, 655 West 12th Avenue, Vancouver, BC, V5Z 4R4, Canada., McGreevy PB; Canadian Institute for Substance Use Research, University of Victoria, PO Box 1700 STN CSC, Victoria, British Columbia, V8W 2Y2, Canada., Burmeister C; British Columbia Centre for Disease Control, 655 West 12th Avenue, Vancouver, BC, V5Z 4R4, Canada., Barker B; First Nations Health Authority, 540-757 West Hastings St, Vancouver, BC, V6C 1A1, Canada., Slaunwhite A; British Columbia Centre for Disease Control, 655 West 12th Avenue, Vancouver, BC, V5Z 4R4, Canada.; School of Public and Population Health, University of British Columbia, 2206 East Mall, Vancouver, BC, V6T 1Z3, Canada., Nosyk B; Centre for Advancing Health Outcomes, St. Paul's Hospital, 570-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada.; Faculty of Health Sciences, Simon Fraser University, 8888 University Dr., Burnaby, BC, V5A 1S6, Canada., Pauly B; Canadian Institute for Substance Use Research, University of Victoria, PO Box 1700 STN CSC, Victoria, British Columbia, V8W 2Y2, Canada.; School of Nursing, University of Victoria, Victoria, BC, V8W 2Y2, Canada.

Publikováno v: Substance abuse treatment, prevention, and policy [Subst Abuse Treat Prev Policy] 2024 Sep 16; Vol. 19 (1), pp. 44. Date of Electronic Publication: 2024 Sep 16.

Effect of clinical signs, endocrinopathies, timing of surgery, hyperlipidemia, and hyperbilirubinemia on outcome in dogs with gallbladder mucocele

Autor: Jaffey, J.A., Pavlick, M., Webster, C.R., Moore, G.E., McDaniel, K.A., Blois, S.L., Brand, E.M., Reich, C.F., Motschenbacher, L., Hostnik, E.T., Su, D., Lidbury, J.A., Raab, O., Carr, S.V., Mabry, K.E., Fox-Alvarez, W., Townsend, S., Palermo, S., Nakazono, Y., Ohno, K., VanEerde, E., Fieten, H., Hulsman, A.H., Cooley-Lock, K., Dunning, M., Kisielewicz, C., Zoia, A., Caldin, M., Conti-Patara, A., Ross, L., Mansfield, C., Lynn, O., Claus, M.A., Watson, P.J., Swallow, A., Yool, D.A., Gommeren, K., Knops, M., Ceplecha, V., de Rooster, H., Lobetti, R., Dossin, O., Jolivet, F., Papazoglou, L.G., Pappalardo, M.C.F., Manczur, F., Dudás-Györki, Z., O’Neill, E.J., Martinez, C., Gal, A., Owen, R.L., Gunn, E., Brown, K., Harder, L.K., Griebsch, C., Anfinsen, K.P., Gron, T.K., Marchetti, V., Heilmann, R.M., Pazzi, P., DeClue, A.E.

Publikováno v: In The Veterinary Journal September 2019 251